Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients

被引:6
作者
Ok, Ebru Sevinc [1 ]
Asci, Gulay [1 ]
Toz, Huseyin [1 ]
Ritz, Eberhard [2 ]
Kircelli, Fatih [1 ]
Sever, Mehmet Sukru [3 ]
Ozkahya, Mehmet [1 ]
Sipahi, Savas [1 ]
Dheir, Hamad [1 ]
Bozkurt, Devrim [1 ]
Omer, Ziya [1 ]
Sahin, Osman Z. [1 ]
Ertilav, Muhittin [1 ]
Ok, Ercan [1 ]
机构
[1] Ege Univ, Div Nephrol, TR-35100 Izmir, Turkey
[2] Heidelberg Univ, Div Nephrol, Heidelberg, Germany
[3] Istanbul Univ, Div Nephrol, Istanbul, Turkey
关键词
HbA1c; mortality; hemodialysis; non-diabetic; glycated hemoglobin; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; INSULIN-RESISTANCE; DIABETIC-PATIENTS; RISK; ASSOCIATION; SURVIVAL; US;
D O I
10.5414/CN108251
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Besides diabetic patients, glycated hemoglobin (HbA(1c)) levels have been reported to predict mortality in non-diabetics patients. However, the importance of HbA(1c) levels in non-diabetic hemodialysis patients still remains unknown. Thus, we aimed to prospectively investigate the impact of HbA(1c) on all-cause and cardiovascular mortality in a large group of prevalent non-diabetic hemodialysis patients. Methods: HbA(1c) was measured quarterly in 489 non-diabetic prevalent hemodialysis patients. Overall and cardiovascular mortality were evaluated over a 3 year follow-up. Results: Mean HbA(1c) level was 4.88 +/- 0.46% (3.5 - 6.9%). During the 28.3 +/- 10.6 months follow-up period, 67 patients (13.7%) died; 31 from cardiovascular causes. In Kaplan-Meier analysis, patients in the lowest (< 4.69%) and highest HbA(1c) (> 5.04%) tertiles had poorer overall survival compared to the middle HbA(1c) tertile (p < 0.001). Adjusted Cox-regression analysis revealed that the highest HbA(1c) tertile was associated with both overall (HR = 3.60, 95% CI 1.57 - 8.27, p = 0.002) and cardiovascular (HR = 6.66, 95% CI 1.51 - 29.4; p = 0.01) mortality. Also, low HbA(1c) levels tended to be associated with overall mortality (HR = 2.26, 95% CI 0.96 - 5.29, p = 0.06). Conclusion: Upper normal HbA(1c) levels are independently associated with cardiovascular and overall mortality in non-diabetic hemodialysis patients, whereas lower HbA(1c) levels are not.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 33 条
[2]  
[Anonymous], 1998, AM J MED, DOI DOI 10.1016/S0002-9343(98)00205-8
[3]   Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study [J].
Arad, Y ;
Newstein, D ;
Cadet, F ;
Roth, M ;
Guerci, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :2051-2058
[4]   RAGE biology, atherosclerosis and diabetes [J].
Barlovic, Drazenka Pongrac ;
Soro-Paavonen, Aino ;
Jandeleit-Dahm, Karin A. M. .
CLINICAL SCIENCE, 2011, 121 (1-2) :43-55
[5]   Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up [J].
Cavalot, Franco ;
Pagliarino, Andrea ;
Valle, Manuela ;
Di Martino, Leonardo ;
Bonomo, Katia ;
Massucco, Paola ;
Anfossi, Giovanni ;
Trovati, Mariella .
DIABETES CARE, 2011, 34 (10) :2237-2243
[6]   Insulin resistance and risk of chronic kidney disease in nondiabetic US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Fonseca, V ;
Bautman, V ;
Whelton, PK ;
He, J .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :469-477
[7]   The metabolic syndrome and chronic kidney disease in US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Jones, DW ;
Batuman, V ;
Fonseca, V ;
Whelton, PK ;
He, J .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :167-174
[8]   Glycated Hemoglobin Predicts Mortality in Nondiabetic Patients Receiving Chronic Peritoneal Dialysis [J].
Chen, Kuan-Hsing ;
Lin, Ja-Liang ;
Lin-Tan, Dan-Tzu ;
Hsu, Ching-Wei ;
Huang, Wen-Hung ;
Yen, Tzung-Hai ;
Weng, Shu-Man ;
Hung, Cheng-Chieh .
AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (06) :567-574
[9]   Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population:: the Hoorn Study [J].
de Vegt, F ;
Dekker, JM ;
Ruhé, HG ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
DIABETOLOGIA, 1999, 42 (08) :926-931
[10]   Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients [J].
Drechsler, Christiane ;
Krane, Vera ;
Ritz, Eberhard ;
Maerz, Winfried ;
Wanner, Christoph .
CIRCULATION, 2009, 120 (24) :2421-2428